Auckland City Hospital

Grafton / Auckland 1023

3 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Extrapulmonary Neuroendocrine Cancer (epNEC), Hemorrhage, Hypertension, Obesity, Overweight, Secondary Prevention, Stroke

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight — Recruiting now
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed